Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""ElNaggar AC"" wg kryterium: Autor


Tytuł :
Same-day discharge after robotic surgery for endometrial cancer.
Autorzy :
Zhang N; Department of Obstetrics and Gynecology, The University of Tennessee Health Science Center, Memphis, TN, USA.
Wilson B; Division of Gynecologic Oncology, West Cancer Center and Research Institute, 7945 Wolf River Blvd., Memphis, TN, 38138, USA.
Enty MA; Department of Obstetrics and Gynecology, The University of Tennessee Health Science Center, Memphis, TN, USA.
Ketch P; Department of Obstetrics and Gynecology, The University of Tennessee Health Science Center, Memphis, TN, USA.
Ulm MA; Division of Gynecologic Oncology, West Cancer Center and Research Institute, 7945 Wolf River Blvd., Memphis, TN, 38138, USA.
ElNaggar AC; Division of Gynecologic Oncology, West Cancer Center and Research Institute, 7945 Wolf River Blvd., Memphis, TN, 38138, USA.
Daily L; Division of Gynecologic Oncology, West Cancer Center and Research Institute, 7945 Wolf River Blvd., Memphis, TN, 38138, USA.
Tillmanns T; Division of Gynecologic Oncology, West Cancer Center and Research Institute, 7945 Wolf River Blvd., Memphis, TN, 38138, USA. .
Pokaż więcej
Źródło :
Journal of robotic surgery [J Robot Surg] 2021 Jul 08. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer.
Autorzy :
Ulm MA; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Redfern TM; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Wilson BR; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Ponnusamy S; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Asemota S; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Blackburn PW; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Wang Y; Department of Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
ElNaggar AC; Division of Gynecologic Oncology, West Cancer Center and Research Institute, Memphis, TN 38138, USA.
Narayanan R; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Pokaż więcej
Źródło :
Journal of personalized medicine [J Pers Med] 2020 Nov 26; Vol. 10 (4). Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Autorzy :
Oaknin A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Friedman CF; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Roman LD; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
D'Souza A; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
Brana I; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Bidard FC; Institut Curie, St Cloud, France.
Goldman J; The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Alvarez EA; University of California, San Francisco, CA, USA.
Boni V; START Madrid Centro Oncologico Clara Campal (CIOCC), Madrid, Spain.
ElNaggar AC; West Cancer Center and Research Institute, Memphis, TN, USA.
Passalacqua R; Oncologia Medica-ASST Istituti Ospitalieri Cremona, Cremona, Italy.
Do KTM; Dana-Farber Cancer Institute, Boston, MA, USA.
Santin AD; Yale School of Medicine, New Haven, CT, USA.
Keyvanjah K; Puma Biotechnology Inc, Los Angeles, CA, USA.
Xu F; Puma Biotechnology Inc, Los Angeles, CA, USA.
Eli LD; Puma Biotechnology Inc, Los Angeles, CA, USA.
Lalani AS; Puma Biotechnology Inc, Los Angeles, CA, USA.
Bryce RP; Puma Biotechnology Inc, Los Angeles, CA, USA.
Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Monk BJ; Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 Oct; Vol. 159 (1), pp. 150-156. Date of Electronic Publication: 2020 Jul 25.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Quinolines/*administration & dosage
Receptor, ErbB-2/*antagonists & inhibitors
Uterine Cervical Neoplasms/*drug therapy
Administration, Oral ; Adult ; Diarrhea/chemically induced ; Diarrhea/diagnosis ; Diarrhea/epidemiology ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Mutation ; Nausea/chemically induced ; Nausea/diagnosis ; Nausea/epidemiology ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/mortality ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects ; Quinolines/adverse effects ; Receptor, ErbB-2/genetics ; Response Evaluation Criteria in Solid Tumors ; Severity of Illness Index ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/mortality
Czasopismo naukowe
Tytuł :
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
Autorzy :
Armstrong DK; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Alvarez RD; Vanderbilt-Ingram Cancer Center.
Bakkum-Gamez JN; Mayo Clinic Cancer Center.
Barroilhet L; University of Wisconsin Carbone Cancer Center.
Behbakht K; University of Colorado Cancer Center.
Berchuck A; Duke Cancer Institute.
Berek JS; Stanford Cancer Institute.
Chen LM; UCSF Helen Diller Family Comprehensive Cancer Center.
Cristea M; City of Hope National Medical Center.
DeRosa M; Patient Advocacy.
ElNaggar AC; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
Gershenson DM; The University of Texas MD Anderson Cancer Center.
Gray HJ; University of Washington/Seattle Cancer Care Alliance.
Hakam A; Moffitt Cancer Center.
Jain A; Fox Chase Cancer Center.
Johnston C; University of Alabama at Birmingham Comprehensive Cancer Center.
Leath CA III; University of Alabama at Birmingham Comprehensive Cancer Center.
Liu J; Dana-Farber/Brigham and Women's Cancer Center.
Mahdi H; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Matei D; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
McHale M; UC San Diego Moores Cancer Center.
McLean K; University of Michigan Rogel Cancer Center.
O'Malley DM; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
Penson RT; Massachusetts General Hospital Cancer Center.
Percac-Lima S; Massachusetts General Hospital Cancer Center.
Ratner E; Yale Cancer Center/Smilow Cancer Hospital.
Remmenga SW; Fred & Pamela Buffett Cancer Center.
Sabbatini P; Memorial Sloan Kettering Cancer Center.
Werner TL; Huntsman Cancer Institute at the University of Utah.
Zsiros E; Roswell Park Comprehensive Cancer Center; and.
Burns JL; National Comprehensive Cancer Network.
Engh AM; National Comprehensive Cancer Network.
Pokaż więcej
Źródło :
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Aug 01; Vol. 17 (8), pp. 896-909.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Ovarian Neoplasms/*diagnosis
Ovarian Neoplasms/*therapy
Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Disease Management ; Female ; Humans ; Neoadjuvant Therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
Autorzy :
ElNaggar AC; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America. Electronic address: .
Hade EM; Department of Biomedical Informatics, Center for Biostatistics at The Ohio State University, Columbus, OH, United States of America.
O'Malley DM; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Liang MI; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Copeland LJ; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Fowler JM; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Salani R; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Backes FJ; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Cohn DE; Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2018 Dec; Vol. 151 (3), pp. 501-505. Date of Electronic Publication: 2018 Sep 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemotherapy, Adjuvant/*methods
Ovarian Neoplasms/*drug therapy
Female ; Humans ; Middle Aged ; National Cancer Institute (U.S.) ; United States
Czasopismo naukowe
Tytuł :
Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.
Autorzy :
Ulm MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, West Cancer Center, 7945 Wolf River Boulevard, Germantown, TN 38138, United States of America. Electronic address: .
ElNaggar AC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, West Cancer Center, 7945 Wolf River Boulevard, Germantown, TN 38138, United States of America. Electronic address: .
Tillmanns TD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, West Cancer Center, 7945 Wolf River Boulevard, Germantown, TN 38138, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2018 Oct; Vol. 151 (1), pp. 124-128. Date of Electronic Publication: 2018 Aug 16.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Celecoxib/*therapeutic use
Cyclooxygenase Inhibitors/*therapeutic use
Endometrial Neoplasms/*surgery
Ketorolac/*therapeutic use
Pain Management/*methods
Pain, Postoperative/*drug therapy
Activities of Daily Living ; Administration, Intravenous ; Administration, Oral ; Adult ; Aged ; Analgesics, Opioid/therapeutic use ; Drug Therapy, Combination/methods ; Female ; Humans ; Hysterectomy/adverse effects ; Hysterectomy/methods ; Middle Aged ; Pain Measurement/drug effects ; Pain, Postoperative/epidemiology ; Pain, Postoperative/etiology ; Robotic Surgical Procedures/adverse effects ; Robotic Surgical Procedures/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Recurrent low grade serous ovarian cancer in a 20 year old woman: A case from the Ohio State University College of Medicine.
Autorzy :
Cohn DE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States. Electronic address: .
Backes FJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Wallbillich JJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Bixel K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Crafton SM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Neff R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
ElNaggar AC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Smith B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, United States.
Suarez AA; Department of Pathology, Ohio State University College of Medicine, Columbus, OH, United States.
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2017 Mar; Vol. 144 (3), pp. 451-455. Date of Electronic Publication: 2017 Feb 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Neoplasm Recurrence, Local/*pathology
Ovarian Neoplasms/*pathology
Adult ; Female ; Humans ; Neoplasm Grading ; Ohio ; Ovarian Neoplasms/therapy ; Young Adult
Czasopismo naukowe
Tytuł :
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Autorzy :
Saini U; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Naidu S; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
ElNaggar AC; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Bid HK; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Wallbillich JJ; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Bixel K; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Bolyard C; Department of Neurological Surgery, The Ohio State University, Columbus, OH.
Suarez AA; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Kaur B; Department of Neurological Surgery, The Ohio State University, Columbus, OH.
Kuppusamy P; Department of Radiology, Dartmouth Medical School, Hanover, NH.
Hays J; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Goodfellow PJ; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Cohn DE; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Selvendiran K; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Pokaż więcej
Źródło :
Oncogene [Oncogene] 2017 Jan 12; Vol. 36 (2), pp. 168-181. Date of Electronic Publication: 2016 Jun 13.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Up-Regulation*/drug effects
Ascites/*pathology
Ovarian Neoplasms/*pathology
STAT3 Transcription Factor/*metabolism
Animals ; Ascites/metabolism ; Cell Movement ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Knockout Techniques ; Humans ; Mice ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Piperidones/administration & dosage ; Piperidones/pharmacology ; STAT3 Transcription Factor/genetics ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective Cohort.
Autorzy :
Backes FJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH; and †Florida Hospital Gynecologic Oncology, Florida Hospital Cancer Institute, Orlando, FL.
ElNaggar AC
Farrell MR
Brudie LA
Ahmad S
Salani R
Cohn DE
Holloway RW
Fowler JM
O'Malley DM
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2016 Nov; Vol. 26 (9), pp. 1717-1721.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Endometrial Neoplasms/*surgery
Laparotomy/*adverse effects
Postoperative Complications/*etiology
Robotic Surgical Procedures/*adverse effects
Aged ; Aged, 80 and over ; Female ; Florida/epidemiology ; Humans ; Ohio/epidemiology ; Postoperative Complications/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
Autorzy :
ElNaggar AC; a Division of Gynecologic Oncology , The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solve Research Institute , Columbus , OH , USA.
Saini U; b Division of Gynecologic Oncology , Comprehensive Cancer Center and Solid Tumor Biology Program, The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Naidu S; b Division of Gynecologic Oncology , Comprehensive Cancer Center and Solid Tumor Biology Program, The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Wanner R; b Division of Gynecologic Oncology , Comprehensive Cancer Center and Solid Tumor Biology Program, The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Sudhakar M; b Division of Gynecologic Oncology , Comprehensive Cancer Center and Solid Tumor Biology Program, The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Fowler J
Nagane M; c Department of Radiology , Dartmouth College Geisel School of Medicine , Hanover , NH , USA.
Kuppusamy P; c Department of Radiology , Dartmouth College Geisel School of Medicine , Hanover , NH , USA.
Cohn DE; a Division of Gynecologic Oncology , The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solve Research Institute , Columbus , OH , USA.
Selvendiran K; b Division of Gynecologic Oncology , Comprehensive Cancer Center and Solid Tumor Biology Program, The Ohio State University Wexner Medical Center , Columbus , OH , USA.
Pokaż więcej
Źródło :
Cancer biology & therapy [Cancer Biol Ther] 2016 Oct 02; Vol. 17 (10), pp. 1107-1115.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Ovarian Neoplasms/*drug therapy
Piperidones/*pharmacology
Drug Resistance, Neoplasm ; Female ; Humans ; STAT3 Transcription Factor/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł :
Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series.
Autorzy :
ElNaggar AC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, United States of America.
Hays JL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, United States of America.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Chen JL; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America.; Division of Bioinformatics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Jun 13; Vol. 11 (6), pp. e0156985. Date of Electronic Publication: 2016 Jun 13 (Print Publication: 2016).
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Bone Neoplasms/*drug therapy
Everolimus/*administration & dosage
Protein Kinase Inhibitors/*administration & dosage
Receptors, Vascular Endothelial Growth Factor/*antagonists & inhibitors
Sarcoma/*drug therapy
Soft Tissue Neoplasms/*drug therapy
Adult ; Bone Neoplasms/pathology ; Chemotherapy, Adjuvant ; Disease Progression ; Everolimus/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Protein Kinase Inhibitors/adverse effects ; Retrospective Studies ; Sarcoma/pathology ; Soft Tissue Neoplasms/pathology ; Treatment Failure
Czasopismo naukowe
Tytuł :
Incidence and contributing factors to termination of the patient-physician relationship.
Autorzy :
Santoso JT; Division of Gynecology Oncology, University of Tennessee-West Cancer Center, Memphis, TN, United States.
Yibirin E; University of Tennessee Health Science Center, Memphis, TN, United States.
Crigger M; Division of Gynecology Oncology, University of Tennessee-West Cancer Center, Memphis, TN, United States.
Wan J; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
ElNaggar AC; Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solve Research Institute, Columbus, OH, United States.
Pokaż więcej
Źródło :
Gynecologic oncology reports [Gynecol Oncol Rep] 2016 May 31; Vol. 17, pp. 42-4. Date of Electronic Publication: 2016 May 31 (Print Publication: 2016).
Typ publikacji :
Case Reports
Raport
Tytuł :
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center.
Autorzy :
Liang MI; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
ElNaggar AC; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Nekkanti S; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
O'Malley DM; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Hade EM; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
Copeland LJ; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Fowler JM; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Salani R; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Backes FJ; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA.
Cohn DE; Division of Gynecologic Oncology Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2015 Sep; Vol. 138 (3), pp. 689-93. Date of Electronic Publication: 2015 Jul 26.
Typ publikacji :
Journal Article
MeSH Terms :
Medical Oncology/*methods
Medical Oncology/*standards
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Female ; Guideline Adherence ; Humans ; Middle Aged ; National Cancer Institute (U.S.) ; Patient Compliance ; Quality of Health Care ; United States
Czasopismo naukowe
Tytuł :
Guided outcomes in learned efficiency model in clinical medical education: a randomized controlled trial of self-regulated learning.
Autorzy :
Patil AS; Departments of Obstetrics and Gynecology and Medicine, Indiana University School of Medicine, Indianapolis, IN.
Elnaggar AC; Department of Gynecology and Obstetrics, the Ohio State University College of Medicine, Columbus, OH.
Kumar S; Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, TN.
Ling FW; Women's Health Specialists, Germantown, TN.
Stritter FT; University of North Carolina School of Medicine, Chapel Hill, NC.
Temiyakarn L; Department of Radiology, University of Tennessee Health Science Center, Memphis, TN.
Tillmanns TD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Tennessee Health Science Center-West Clinic, Memphis, TN.
Pokaż więcej
Źródło :
American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2014 Nov; Vol. 211 (5), pp. 544.e1-7. Date of Electronic Publication: 2014 Jun 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Clinical Competence*
Education, Medical, Undergraduate/*methods
Evidence-Based Medicine/*education
Adult ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer.
Autorzy :
Rath KS; Authors' Affiliations: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Comprehensive Cancer Center; Center for Childhood Cancer, Nationwide Children's Hospital; Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center; EPR Imaging Center, Geisel School of Medicine, Dartmouth, New Hampshire; and Institute of Organic and Medicinal Chemistry, University of Pécs, Pécs, Hungary.
Naidu SK
Lata P
Bid HK
Rivera BK
McCann GA
Tierney BJ
Elnaggar AC
Bravo V
Leone G
Houghton P
Hideg K
Kuppusamy P
Cohn DE
Selvendiran K
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2014 Apr 15; Vol. 74 (8), pp. 2316-27. Date of Electronic Publication: 2014 Mar 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Ovarian Neoplasms/*drug therapy
Piperidones/*pharmacology
STAT3 Transcription Factor/*antagonists & inhibitors
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; CHO Cells ; Cell Growth Processes/drug effects ; Cell Line, Tumor ; Cricetulus ; Cytotoxicity, Immunologic ; Female ; Humans ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; STAT3 Transcription Factor/metabolism ; Signal Transduction ; Transcriptional Activation ; Transfection ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
In reply.
Autorzy :
ElNaggar AC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2014 Jan; Vol. 123 (1), pp. 184.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anus Neoplasms/*epidemiology
Carcinoma in Situ/*epidemiology
Genital Neoplasms, Female/*epidemiology
Female ; Humans
Opinia redakcyjna
Tytuł :
Risk factors for anal intraepithelial neoplasia in women with genital dysplasia.
Autorzy :
ElNaggar AC; Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, and the Division of Gynecologic Oncology, University of Tennessee-West Clinic, Memphis, Tennessee.
Santoso JT
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2013 Aug; Vol. 122 (2 Pt 1), pp. 218-223.
Typ publikacji :
Journal Article
MeSH Terms :
Anus Neoplasms/*epidemiology
Carcinoma in Situ/*epidemiology
Genital Neoplasms, Female/*epidemiology
Adult ; Anus Neoplasms/complications ; Anus Neoplasms/diagnosis ; Carcinoma in Situ/complications ; Carcinoma in Situ/diagnosis ; Female ; Genital Neoplasms, Female/complications ; Humans ; Logistic Models ; Middle Aged ; Prospective Studies ; Risk Factors ; Tennessee/epidemiology
Czasopismo naukowe
Tytuł :
Endometrial cancer in a 15-year-old girl: A complication of Cowden Syndrome.
Autorzy :
Elnaggar AC; Department of Obstetrics & Gynecology, University of Tennessee Health Science Center, Memphis, TN, USA.
Spunt SL; Departments of Oncology and Pediatric Medicine, St. Jude Children's Research Hospital & Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
Smith W; Crossville Gynecology Associates, Crossville, TN, USA.
Depas M; University of Tennessee Health Science Center, West Clinic, Memphis, TN, USA.
Santoso JT; Division of Gynecologic Oncology, University of Tennessee Health Science Center, West Clinic, Memphis, TN, USA.
Pokaż więcej
Źródło :
Gynecologic oncology case reports [Gynecol Oncol Case Rep] 2012 Oct 26; Vol. 3, pp. 18-9. Date of Electronic Publication: 2012 Oct 26 (Print Publication: 2012).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies